The Epilepsy Institute of New Jersey is a team of board-certified neurologists and neurosurgeons who provide expert care for a variety of pediatric neurological conditions, including Dravet syndrome. Our team uses advanced diagnostic tools and innovative treatment techniques to ensure the best outcomes for your child.
The Physical Impact
Dravet syndrome is a rare, genetic form of epilepsy that typically begins in the first year of life. It is characterized by prolonged, frequent, and severe seizures that may be triggered by factors such as fever or warm temperatures. Over time, children with Dravet syndrome may experience developmental delays, challenges with motor skills, and difficulties with communication and social interaction. Early diagnosis and a personalized treatment plan can help reduce seizure frequency and improve a child's quality of life.
How Common Is This Condition?
Dravet syndrome is relatively rare, affecting approximately 1 in every 15,000 to 40,000 children. It is often caused by mutations in the SCN1A gene, though other genetic variations can also be involved. Recognition of early signs and prompt referral to a specialist are essential for effective management.
Risk Factors:
- Genetic mutations (commonly SCN1A)
- Family history of epilepsy or related conditions
- Early onset of severe seizures in infancy
Signs and Symptoms
Children with Dravet syndrome may experience various types of seizures and developmental challenges, including:
- Prolonged, recurrent seizures often triggered by fever, heat, or bright lights
- Frequent generalized tonic-clonic (convulsive) seizures
- Myoclonic seizures (brief, shock-like muscle jerks)
- Developmental delays, including speech and motor impairments
- Behavioral challenges and difficulties with attention or learning
- Increased risk of Sudden Unexpected Death in Epilepsy (SUDEP)
How We Diagnose
At the Epilepsy Institute of New Jersey, diagnosing Dravet syndrome involves a thorough evaluation of your child's medical history, seizure patterns, and genetic background. Our diagnostic approach may include:
- EEG (Electroencephalogram): Measures electrical activity in the brain to identify characteristic seizure patterns.
- Genetic Testing: Detects mutations commonly associated with Dravet syndrome, such as SCN1A.
- MRI (Magnetic Resonance Imaging): Rules out structural brain abnormalities that may contribute to seizures.
- Neurodevelopmental Assessments: Evaluates cognitive, motor, and communication skills impacted by the condition.
This comprehensive assessment allows us to confirm the diagnosis and develop a targeted treatment plan.
Treatment Options
Managing Dravet syndrome focuses on reducing seizure frequency, preventing prolonged episodes, and supporting overall development. Treatment options may include:
- Medications: Anti-seizure drugs specifically chosen for their effectiveness in Dravet syndrome.
- Specialized Diets: The ketogenic or modified Atkins diet can help control difficult-to-treat seizures.
- Medical Devices: Vagus nerve stimulation (VNS) or other implantable devices may help reduce seizure severity.
- Therapeutic Support: Physical, occupational, and speech therapies assist with developmental challenges and improve quality of life.
The Epilepsy Institute of New Jersey adopts a multidisciplinary approach to care, working closely with families, therapists, and educators to provide comprehensive support for children with Dravet syndrome.
Our Commitment to Your Child's Health
“I am neurosurgeon living in New Jersey, board-certified by both the American Board of Neurosurgery (ABNS) and Pediatric Neurosurgery (ABPNS). I specialize in the surgical treatment of complex epilepsy and serve as the Director of the Epilepsy Institute of New Jersey, Chief of Pediatric Epilepsy Surgery at Sanzari Children's Hospital, and Chief of Pediatric Neurosurgery at Children's Hospital of NJ, where I provide exceptional care for children with complex neurological conditions. Your child's health and well-being are our top priorities.”
